The biopharmaceutical and pharmaceutical industries are investing more in research R&D, which is propelling the global laboratory filtration market forward.
Covid-19 Impact & Market Status
As a result of the COVID-19 outbreak, the global laboratory filtration market is predicted to grow. Researchers are employing a variety of laboratory items, including filters, to conduct diverse research ranging from virus detection to vaccine production. Pall laboratory's Acrodisc sterile syringe filters, for example, protect the sterility of media, kits, and components used in COVID-19 research kits. Changes in consumer behavior about health and hygiene goods as a result of the global coronavirus pandemic are inadvertently driving membrane filtration adoption. The bulk of demand in the laboratory filtration market is for different food, healthcare, and wastewater treatment applications, which are critical income sources. The market is growing as a result of a rising number of businesses seeking solutions for health and safety regulations in the workplace.
The Filtration Assembly Segment will hold the Maximum Market Share in the Predicted Period.
The filtration media sub-segment of the laboratory filtration industry is likely to develop at the quickest rate throughout the estimated period. The significant use of filtering media in many sectors, such as the food and beverage industry, accounts for the big share of this market. Because of their high usage and the necessity for recurring purchases, they have a greater market share and are growing at a faster rate.
The Microfiltration Segment is accounted for the Maximum Revenue in the Predicted Period.
In 2020, the microfiltration sub-segment accounted for the maximum revenue of the market. This is due to the growing usage of microfiltration membranes as a prefilter for ultrafiltration and reverses osmosis, as well as increased pharmaceutical and biologics research and development.
The Pharmaceutical and Biotechnology Segment will occupy the Majority of the Market Share in the Coming Future.
In 2020, the pharmaceutical and biotechnology segment held the highest market share. The considerable proportion of this sector is due to the widespread use of lab filtration in pharmaceutical and biotechnology businesses for the creation of big pharmacological compounds. Furthermore, as rules for the manufacture of defect-free end products become more stringent, the pharmaceutical and biotechnology industries will place a greater emphasis on quality control methods, which will promote market development.
North American Market for the Laboratory Filtration is Likely to grow with the Maximum Revenue
The North American region will account for the maximum share of the laboratory filtration industry by 2020. As a consequence of increased health and environmental concerns, strict standards limiting the quality of culture media and reagent grade have been adopted, resulting in a significant proportion of North America. Furthermore, increased medication development research will raise demand, resulting in regional growth during the predicted period.
The global laboratory filtration market has increased due to an increasing emphasis on developing large molecule biopharmaceuticals.
Laboratory filtration is a separation procedure that involves putting solid particles on a filter material to remove them from a liquid or gas. Laboratory filtration machines are utilized in a variety of research settings, including pharmaceutical companies, development labs, and biotechnology companies. Laboratory filtration techniques include ultrafiltration, vacuum filtration, nanofiltration, reverse osmosis, and microfiltration. Microfiltration is one of the technologies that use a microporous membrane to remove pollutants from air or liquid.
Consolidation of laboratory sections and the formation of central core laboratories have typically resulted in cost reductions in clinical laboratories. Furthermore, laboratory personnel are instructed to concentrate on technical performance as well as the maintenance and achievement of the highest possible quality test results. As a result, the market is being propelled ahead by the increasing usage of filtering methods in clinical labs.
Microfiltration topped the global laboratory filtration market, thanks to its widespread use in a variety of industries for solid-liquid phase separation as well as cold sterilization of API and enzymes. The two most important factors driving microfiltration adoption in the industry studied are chemical resistance and excellent thermal stability. Microfiltration offers a high separation capacity and requires no additional solvents, making it an easy to use and deploy technique.
The market is predicted to rise due to an increase in demand for high-production filtration goods throughout the downstream process, the introduction of complex filtration technologies for ultra-purification, and the increased use of analytical equipment. Qualitative filter papers and ashless filter papers are offered from GE Healthcare, Macherey-Nagel, and Hahnemühle and are designed specifically for quantitative routine analytical processes and general laboratory filtering. Similarly, the laboratory filtration market is expected to grow as more advanced filtration technologies such as nanofiltration, microfiltration, and ultrafiltration, which employ superior filtration equipment, become available. Furthermore, the quick improvements in nanofiber technology, as well as the rapid growth in the usage of filtering technologies in pharmaceutical and biopharmaceutical laboratories are expected to present significant potential opportunities for the market throughout the forecast period.
To get a larger market share, leading industry businesses are forming partnerships and buying other vehicle logistics companies through mergers and acquisitions. Furthermore, to get a competitive edge among end-users, industry participants are focused on developing automation technologies. 3M Company, Steris (Cantel Medical Corporation), Antylia Scientific, Merck KGaA, Agilent Technologies, Inc., Danaher Corporation, Sartorius AG, Sterlitech Corporation, and Veolia Water Technologies are among the companies involved. Financial overviews, company goals, corporate biographies, and current events were used to identify these market players.
Latest Innovations in the Global Laboratory Filtration Market: a Snapshot
- In December 2021, LeChase opens a new training center to train workers in cutting-edge noise and dust control systems for hospital and laboratory construction projects.
- In December 2021, Nanoscience Analytical, based in Phoenix, Arizona, has increased its laboratory capabilities and workforce to meet the demands of its expanding client base. The analytical firm provides a comprehensive range of services to a variety of businesses, including microscopy and elemental analysis.
The purpose of this global market research report is to give detailed information on the laboratory filtration market. The research analyses the market's growth potential, demographics, and capacity throughout the anticipated period. This component supports the calculation of market size as well as market growth projections during the evaluation period.
Laboratory Filtration Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2028||USD 6808 million|
|Growth Rate||CAGR of 9% during 2021-2028|
|Segment Covered||Product, Technology, End User, Regions|
|Regions Covered||North America, Europe, Asia Pacific, Middle East and Africa, South America|
|Key Players Profiled||developing automation technologies. 3M Company, Steris (Cantel Medical Corporation), Antylia Scientific, Merck KGaA, Agilent Technologies, Inc., Danaher Corporation, Sartorius AG, Sterlitech Corporation, and Veolia Water Technologies|
Key Segments of the Global Laboratory Filtration Market
Product Overview, 2018-2028 (USD Million)
- Filtration Assembly
- Filter Media
Technology Overview, 2018-2028 (USD Million)
- Reverse Osmosis
End User Overview, 2018-2028 (USD Million)
- Food & Beverage Industry
- Academic & Research Institutions
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
Regional Overview, 2018-2028 (USD Million)
- Rest of Europe
- Rest of Asia Pacific
- Rest of South America
The Middle East and South Africa